Interactive Program Guide
Put your cursor over the icon or photo for a capsule summary or to learn more about our speakers

 8.30-9.00
The time between virological failure and failure defined by CD4 count or disease progression is months (or years) allowing accumulation of viral mutations which compromise the second line regimen. Inexpensive point-of-care VL testing could change this.

 CD4 and viral load testing in low and middle income countries [ Download ]

 Robert Oelrichs
 Senior HIV/AIDS Specialist, Global HIV/AIDS Program, The World Bank,
 Washington, DC

9.00-9.30
The much publicized flight from the US to Europe by a person with XDRTB resulted in 100's of passengers being screened and put XDRTB in the spotlight. Here we look at the evolution, spread, diagnostic approach and treatment of this emerging threat

 The Travels of XDRTB [ Download ]

 Anton Pozniak
 Consultant Physician and Honorary Senior Lecturer at St Stephen’s Centre,
 Chelsea & Westminster NHS Trust

9.30-10.00
Treatment of Hepatitis C (with or without HIV co-infection) remains largey ignored in low and middle income countries.While cost is undoubtedly an issue, the burden of disease on communities posed by hepatitis C is growing enormously. What can be done?

 Management of HIV/hepatitis C co-infection : A public health priority
[ Download ]

 Greg Dore
 Associate Professor and Head, Viral Hepatitis Clinical Research Program,
 National Centre in HIV Epidemiology and Clinical Research, The University of
 New South Wales, Sydney. Infectious Diseases Physician, St Vincent’s Hospital,
 Sydney.
BREAK

10.30 -11.00
A review of the most recent guidelines on HIV treatment during pregnancy and approaches to conception for both HIV-concordant and HIV-discordant couples. The prtesentatio will also include an update on the prevention of mother to child transmission

 HIV and Pregnancy [ Download ]

 Lynne Mofenson
 Pediatric, Adolescent & Maternal AIDS Branch, National Institute of Child Health
 & Human Development, National Institutes of Health, Department of Health and
 Human Services

11.00-11.30
DR Thanyawee will review new research and new guidelines in the management of children with HIV

 Management of Pediatric HIV Infection [ Download ]

 Thanyawee Puthanakit
 Dr.Thanyawee is Assistant Professor of Pediatrics at the Research Institute for
 Health Sciences, Chiang Mai University and HIVNAT project leader of the
 PREDICT paediatric clinical trial

 11.30-12.00
While the Indian pharmaceutical industry has led the world in making affordable ART available, the challenges to scaling up ART in this populous and diverse country are enormous.

 Scaling up ARV access in India [ Download ]

 Nagalingeswar-an Kumarasamy
 Chief Medical Officer and Clinical Researcher, YRG Centre for AIDS Research and
 ducation, Principal Investigator - ACTG  International Clinical Trials Unit, Chennai,
 INDIA

Satellite Lunchtime Symposium by JANSSEN-CILAG 12.00-13.30 [ Download ]

WORKSHOPS
A chance to sit in a small group and ask questions or listen to others discuss with our experts. Get up and move around to the different skills stations and experts to get the most out of this afternoon
Cases in the clinic 		Convened by amFAR, the objective of this workshop is raise awareness of the lack of treatment for hepatitis C. Drug cost is the barrier but, as in HIV, this can be changed if there is Government, community and health professional will
Hepatitis C A Public Health Priority

A chance to update knowledge on the prevention and the management of HIV infection in children
Paediatric workshop
 
     
 
 
 
Copyrights 2007 HIV-NAT. All rights reserved